Telatinib: A Potent Multi-Kinase Inhibitor for Advanced Cancer Research and Development
Explore the advanced anti-cancer properties of Telatinib, a key player in targeted therapy and drug discovery.
Get a Quote & SampleProduct Core Value
Telatinib
Telatinib (CAS 332012-40-5) stands out as a potent small molecule inhibitor, demonstrating significant efficacy in targeting critical kinases involved in cancer progression. Its ability to inhibit VEGFR2/3, c-Kit, and PDGFRα makes it a valuable tool in oncological research and therapeutic development.
- Discover the role of Telatinib in inhibiting VEGFR2/3, c-Kit, and PDGFRα, crucial for tumor angiogenesis and growth.
- Learn how Telatinib can be used to reverse chemotherapeutic multidrug resistance, enhancing treatment efficacy.
- Explore the research applications of Telatinib as a potent multi-kinase inhibitor in preclinical cancer studies.
- Understand the significance of Telatinib CAS 332012-40-5 in developing novel anti-cancer strategies and targeted therapies.
Key Advantages
Potent Kinase Inhibition
Telatinib exhibits high potency against key cancer-related kinases, making it a valuable compound for research into targeted cancer therapy and understanding disease mechanisms.
Multi-Target Action
With its ability to inhibit multiple kinases like VEGFR, c-Kit, and PDGFRα, Telatinib offers a comprehensive approach to targeting complex cellular pathways involved in tumor development and metastasis.
Drug Resistance Reversal
Research indicates Telatinib's capacity to overcome multidrug resistance in cancer cells, offering a potential pathway to improve the effectiveness of existing chemotherapies.
Key Applications
Oncology Research
Telatinib is extensively used in preclinical research to investigate mechanisms of tumor growth, angiogenesis, and to develop new anti-cancer drugs.
Targeted Therapy Development
As a selective kinase inhibitor, Telatinib serves as a vital compound for the development of targeted therapies aimed at specific cancer-driving pathways.
Drug Discovery Tool
Researchers utilize Telatinib to explore new therapeutic strategies and identify biomarkers for response in various solid tumor types.
Pharmaceutical Intermediate
The compound serves as a critical API for pharmaceutical companies engaged in the research and development of novel oncology treatments.